Evidence map›Paper›PMID 34523266›Full record

ArticleAdvanced healthcare materials2021

Polymyxin B-Triggered Assembly of Peptide Hydrogels for Localized and Sustained Release of Combined Antimicrobial Therapy.

Yejiao Shi, David W Wareham, Yichen Yuan, Xinru Deng, Alvaro Mata, Helena S Azevedo

Open access · hybridAbstract read
In one paragraph

Article in Advanced healthcare materials, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Nanomaterials (Basel, Switzerland) · 2025
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Using theMicrobiology (Reading, England) · 2023
    Article
  15. Article
  16. Strategies for Improving Peptide Stability and Delivery.Pharmaceuticals (Basel, Switzerland) · 2022
    Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yejiao ShiSchool of Engineering and Materials Science, Queen Mary University of London, London, E1 4NS, UK.
David W WarehamCenter for Immunobiology, The Blizard Institute, Barts and The London, School of Medicine and Dentistry, Queen Mary University of London, London, E1 2AT, UK.
Yichen YuanSchool of Engineering and Materials Science, Queen Mary University of London, London, E1 4NS, UK.
Xinru DengSchool of Engineering and Materials Science, Queen Mary University of London, London, E1 4NS, UK.
Alvaro MataSchool of Pharmacy, University of Nottingham, Nottingham, NG7 2RD, UK.
Helena S AzevedoSchool of Engineering and Materials Science, Queen Mary University of London, London, E1 4NS, UK.ORCID 0000-0002-5470-1844
Queen Mary University of London · GBUniversity of Nottingham · GB

Funding

Medical Research Council MR/R015651/1Wellcome TrustWellcome Trust 210122/Z/18/Z
6 · The paper itself

Abstract

Repurposing old antibiotics into more effective and safer formulations is an emergent approach to tackle the growing threat of antimicrobial resistance. Herein, a peptide hydrogel is reported for the localized and sustained release of polymyxin B (PMB), a decade-old antibiotic with increasing clinical utility for treating multidrug-resistant Gram-negative bacterial infections. The hydrogel is assembled by additing PMB solution into a rationally designed peptide amphiphile (PA) solution and its mechanical properties can be adjusted through the addition of counterions, envisioning its application in diverse infection scenarios. Sustained release of PMB from the hydrogel over a 5-day period and prolonged antimicrobial activities against Gram-negative bacteria are observed. The localized release of active PMB from the hydrogel is shown to be effective in vivo for treating Pseudomonas aeruginosa infection in the Galleria mellonella burn wound infection model, dramatically reducing the mortality from 93% to 13%. Complementary antimicrobial activity against Gram-positive Staphylococcus aureus and enhanced antimicrobial effect against the Gram-negative Acinetobacter baumannii are observed when an additional antibiotic fusidic acid is incorporated into the hydrogen network. These results demonstrate the potential of the PMB-triggered PA hydrogel as a versatile platform for the localized and sustained delivery of combined antimicrobial therapies.

Indexed as

HydrogelsPolymyxin BAnti-Bacterial AgentsDelayed-Action PreparationsMicrobial Sensitivity TestsAnti-Bacterial AgentsDelayed-Action PreparationsHydrogelsPolymyxin Bantimicrobialcombined therapyhydrogelslocal deliverypeptide amphiphilespolymyxins

Identifiers

PMID34523266
PMCPMC11469027
OpenAlexW3200567888

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.